Fresh out of 6 Dimensions' incubator, Curon launches with $150M and backing from Boyu, Temasek
The latest mega-round in the China biotech scene features some of the hottest VCs — and a pretty mysterious startup.
Curon Biopharmaceuticals has reaped $150 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
